Market News beta
Aurora Cannabis Starts Trading on Toronto Stock Exchange
Company Will Ring the Bell to Open the Market Monday, July 24
VANCOUVER, July 21, 2017
/CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (TSXV: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) announced today that common shares of the Company will commence trading on Toronto Stock Exchange (the "TSX") effective Monday July 24. Common shares will continue to trade under the symbol "ACB". In conjunction with listing on TSX, the common shares have been voluntarily delisted from TSX Venture Exchange, effective close of trading today, Friday, July 21, 2017. Aurora will "ring the bell" to open TSX on Monday, July 24, 2017.
"Aurora's graduation to TSX reflects the remarkable commercial and operational progress we have made since listing on TSX Venture Exchange late last year," said Terry Booth, CEO. "We are achieving record yields at our Mountain View County production facility, progressing rapidly with the construction of our 100,000+ kg per annum Aurora Sky facility at Edmonton International Airport, and are executing consistently on our national and international expansion strategy. The acquisition of our third production facility, in Pointe-Claire, Québec will further support our domestic growth. Our acquisition of Pedanios, Germany's largest medical cannabis distributor, and our strategic investment in Australia's Cann Group, have established Aurora as a global leader in the cannabis sector. Aurora continues to drive innovation in the industry, as evidenced by our research collaboration with and investment in Radient Technologies, the launch and upgrades of our one-of-a-kind mobile application, and the expansion of our same-day and next-day delivery program. We expect that graduating to TSX will further increase our shareholder audience, and represents another important strategic step in enhancing shareholder value."
Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations ("ACMPR"). The Company operates a 55,200 square foot, state-of-the-art production facility in Mountain View County, Alberta, and is currently constructing a second 800,000 square foot production facility, known as "Aurora Sky", at the Edmonton International Airport, and has acquired, and is undertaking completion of, a third 40,000 square foot production facility in Pointe-Claire, Quebec, on Montreal's West Island. In addition, the company is the cornerstone investor with a 19.9% stake in Cann Group Limited, the first Australian company licensed to conduct research on and cultivate medical cannabis, as well as owns Pedanios, a leading wholesale importer, exporter, and distributor of medical cannabis in the European Union ("EU"), based in Germany. Aurora's common shares now trade on TSX under the symbol "ACB".
On behalf of the Board of Directors,
AURORA CANNABIS INC.
Terry Booth, CEO
This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Neither TSX nor TSX Venture Exchange (nor its Regulation Services Provider as that term is defined in the policies of TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE Aurora Cannabis Inc.
For further information: For Aurora Cannabis Inc.: Cam Battley, Executive Vice President, +1.905.864.5525, email@example.com, www.auroramj.com; Marc Lakmaaker, NATIONAL Equicom, firstname.lastname@example.org , +1.416.848.1397
original source: http://www.newswire.ca/news-releases/aurora-cannabis-starts-trading-on-toronto-stock-exchange-635823983.html
Puration Grow Operation Acquisition with $1.2 Million First Year Outlook and $16 Million Near Term Growth Plan to Be Presented in Online Presentation July 25
Jul 21, 2017:
DALLAS, TX / ACCESSWIRE / July 21, 2017 / Puration, Inc. (OTC PINK: PURA) today announced an online on demand presentation scheduled for Tuesday next week, July 25, 2017. The presentation will be published on the Company website (purationinc.com) to provide an overview of the plan to realize the first $1.2 million in sales and expand over the near term to $16 million in sales from the Company's recently announced 25-greenhouse grow operation. The sales plan from the grow operation is separate from the Company's ongoing cannabis infusion business lines. PURA operates a U.S. Patented Cannabis Extraction Process and sells its extracts for infusion into a variety of consumer products to include beverages, foods, nutritional supplements, and cosmetics. The grow operation, acquired as of yesterday, will provide PURA the opportunity to refine its own strains of cannabis to further enhance the efficacy of its extracts.
Yesterday, PURA announced the acquisition of a 25-greenhouse grow operation. The Company also recently announced a $1.2 million sales contract executed in anticipation of the acquisition. The grow operation has the potential to expand production to another 400 irrigated greenhouse pads ready for buildout. Management anticipates the operations have the potential to expand to as high as $16 million in annual sales in the not too distant future, and substantially higher to well over $100 million in annual sales as the legalization process for medical marijuana matures. Forbes reported that marijuana sales in the U.S. last year were over $6 billion, and that marijuana sales in the U.S are anticipated to exceed $20 billion by 2021. Look for an online presentation from the Company next week about the overall strategy behind the acquisition to include more insight on the timing of the opportunity to reach $16 million in annual sales and beyond.
Learn More About PURA: purationinc.com
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Brian Shibley, CEO
SOURCE: Puration, Inc.
Copyright © 2017 Accesswire. All Rights Reserved
Vape Holdings provides clarity on its HIVE Ceramics Product Line
Jun 01, 2017
AGOURA HILLS, CA--(Marketwired - Jun 1, 2017) - Vape Holdings, Inc. (OTCQB: VAPE) (the "Company" or "Vape"), a holding company focused on providing healthy, efficient, and sustainable vaporization products, wants to provide the following operational update to investors.
Through its subsidiary HIVE Ceramics, the Company will continue operating and expanding its premier brand by further collaborating with industry leaders, releasing its own innovative designs and supplying its products to newcomers of this rapidly growing market. In an effort to communicate with and educate investors about HIVE, the Company would like to highlight some of its branded products and collaborations that have already become a staple in the industry.
Benjamin Beaulieu, Vape's CEO shared these highlights of the HIVE Ceramics product line:
"We have had very strong support for our D-NAIL® collaborations. These products pair with an electronic heated coil in order to give the end user an elevated level of control over what temperature they prefer to vaporize concentrates or essential oils. This control is ideal for consumers because it allows them to take advantage of all the benefits of ceramic versus other materials without being experienced with a Crème Brûlée torch (the common method of heating these elements)."
"We would like to highlight a few of our popular products, which include collaborations with one of the top brands in the industry; Quave Club Banger (QCB). We have released both male and female oriented ceramic Club Bangers as well as our in house ceramic Banger Cap. The Banger Cap is a sleek and compact carb cap with dabber that fits over the ceramic Club Banger like a glove."
"One of HIVE's first designs that remains a fan favorite is the Carb Cap with Stinger. Its universal fit allows this product to function with a majority of applications available today."
"HIVE launched the ONYX 14mm Domeless in 2016 and its quality has exceeded all of our expectations. The ONYX is the only Silicon Nitride application in the industry and helps to further cement the position of HIVE as a leader in innovation and design. We are working to release new products in this material before the end of 2017."
"As is common with Brothership Glass, the Ceramic Honey Bucket collaboration is designed specifically for the vaping connoisseur. Complex function paired with a one of a kind vaporizing experience, the Ceramic Honey Bucket is the Ferrari of our product line."
"We are continuing discussions regarding more collaborations and partnerships at all levels of the industry. We look forward to sharing more updates soon regarding the strategic and business development efforts we have described previously," Mr. Beaulieu concluded.
As the Medical Cannabis market continues to expand and more states adopt "recreational" guidelines, our target consumer base will grow accordingly. VAPE management believes that recent and future developments will help improve their position to take advantage of these market dynamics. The Company looks forward to participating in the growth and opportunities for the Cannabis industry now and long into the future.
About VAPE Holdings, Inc.
VAPE Holdings, Inc. focuses on designing, marketing, and distributing various vaporization products. The company offers medical and food grade ceramic products primarily under the HIVE Ceramics brand throughout North America, Europe and South America. HIVE offers a nonporous, non-corrosive, chemically inert ceramic vaporization element, which can be used for a range of applications, including stand-alone vaporization products and electronic cigarettes. The company is based in Agoura Hills, California.
For more information on HIVE Ceramics and to visit our e-commerce site, please visit: http://www.hiveceramics.com.
For more information on Revival and to visit our e-commerce site, please visit: http://www.revivalvapes.com.
Cautionary Language Concerning Forward-Looking Statements
This release contains "forward-looking statements" that include information relating to future events and future financial and operating performance. The words "may," "would," "will," "expect," "estimate," "can," "believe," "potential" and similar expressions and variations thereof are intended to identify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause these differences include, but are not limited to: fluctuations in demand for VAPE Holdings' products, the introduction of new products, the Company's ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company's liquidity and financial strength to support its growth, and other information that may be detailed from time-to-time in VAPE Holdings' filings with the United States Securities and Exchange Commission. Examples of such forward-looking statements in this release include statements regarding future sales, costs and market acceptance of products as well as regulatory actions at the State or Federal level. For a more detailed description of the risk factors and uncertainties affecting VAPE Holdings please refer to the Company's Securities and Exchange Commission filings, which are available at www.sec.gov. VAPE Holdings undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.